Selatinib Ditosilate | Interleukin Related interleukin-related.com

Product Name :
Selatinib Ditosilate

Search keywords :
Selatinib

drugId :
null

Target Vo:
Epidermal growth factor receptor erbB1

Target Vo Short Name :
EGFR

Moa_Name:
Epidermal growth factor receptor erbB1 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Qilu Pharmaceutical Co Ltd

Active Company_Name :
Qilu Pharmaceutical Co Ltd

Active Indication_Name:
Breast Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Claudin 18.2 Antibody Purity
FABP4 Rabbit mAb In stock
BMAL1 Antibody: BMAL1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to BMAL1. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts